Challenges in clinical trial design in inflammatory arthritis

Best Practice and Research: Clinical Rheumatology

Volumn 24, Issue 4, 2010, Pages 457-461

  O'Dell, James R ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

clinical trials; comparative effectiveness research; ethics; rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ANTIRHEUMATIC AGENT; IMMUNOSUPPRESSIVE AGENT;

CLINICAL TRIAL; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DRUG INDUSTRY; FUNDING; INTEGRATED HEALTH CARE SYSTEM; MEDICAL ETHICS; METHODOLOGY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RESEARCH SUBJECT; REVIEW; RHEUMATOID ARTHRITIS; CLINICAL TRIAL (TOPIC); DRUG COMBINATION; ECONOMICS; HUMAN; RHEUMATOLOGY;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RESEARCH DESIGN; RHEUMATOLOGY;

EID: 77956168403     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.berh.2009.11.008     Document Type: Review

References (30)

1. J.R. Kirwan, and The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group The effect of glucocorticoids on joint destruction in rheumatoid arthritis N Engl J Med 333 1995 142 146
2. J. O'Dell, C. Haire, and N. Erikson Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications N Engl J Med 334 1996 1287 1291
3. M. Boers, A.C. Verhoeven, and H.M. Markusse Random comparison of combination step-down prednisolone, methotrexate and sulfasalazine with sulfasalazine alone in early rheumatoid arthritis Lancet 350 1997 309 318
4. R. Möttönen, P. Hannonen, and M. Leirisalo-Repo Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomized trial Lancet 353 1999 1568 1573
5. A.A. van Everdingen, J.W. Jacobs, D.R. Siewertsz van Reesema, and J.W. Bijlsma Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial Ann Intern Med 136 1 2002 1 12
6. J. O'Dell, R. Leff, and G. Paulsen Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial Arthritis Rheum 46 5 2002 1164 1170
7. C. Grigor, H.A. Capell, and A. Stirling Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomized controlled trial Lancet 364 2004 263 269
8. Y.P. Goekoop-Ruiterman, J.K. de Vries-Bouwstra, and C.F. Allaart Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial Arthritis Rheum 52 2005 3381 3390
9. H. van Dongen, J. van Aken, and L.R. Lard Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis Arthritis Rheum 56 2007 1424 1432
10. R.F. van Vollenhoven, S. Ernestam, and P. Geborek Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet 374 2009 459 466
11. M.J. Elliott, R.N. Maini, and M. Feldman Randomized, double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor (cA2) versus placebo in rheumatoid arthritis Lancet 344 1994 1105 1110
12. L.W. Moreland, S.W. Baumgartner, and M.H. Schiff Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein N Engl J Med 337 1997 141 147
13. E. Keystone, M. Weinblatt, and D. Furst The ARMADA trial: a double-blind placebo controlled trial of the fully human anti-TNF monoclonal antibody, adalimumab (D2E7) in patients with active RA on methotrexate (MTX) Arthritis Rheum 44 9 2001 S213
14. S. Cohen, E. Hurd, and J. Cush Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate Arthritis Rheum 46 3 2002 614 624
15. J.M. Kremer, R. Westhovens, and M. Leon Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig N Engl J Med 349 2003 1907 1915
16. J.C. Edwards, L. Szczepanski, and J. Szechinski Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N Engl J Med 350 25 2004 2572 2581
17. J. Kay, E.L. Matteson, and B. Dasgupta Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study Arthritis Rheum 58 2008 964 975
18. E. Keystone, D. Heijde, and D. Mason Jr. Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study Arthritis Rheum 58 2008 3319 3329
19. J.S. Smolen, A. Beaulieu, and A. Rubbert-Roth Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomized trial Lancet 371 2008 987 997
20. M.E. Weinblatt, J.M. Kremer, and A.D. Bankhurst A trial of Etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate N Engl J Med 340 1999 253 259
21. P.E. Lipsky, M.F.M. Desiree, and Heijde M.D. van der Infliximab and methotrexate in the treatment of rheumatoid arthritis N Engl J Med 343 22 2000 1594 1602
22. J.M. Kremer, H.K. Genant, and L.W. Moreland Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis Ann Intern Med 144 2006 865 876
23. P. Emery, R. Fleischmann, and A. Filipowicz-Sosnowska The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a Phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial. Arthritis Rheum 54 2006 1390 1400
24. J.M. Kremer, M.C. Genovese, and G.W. Cannon Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 137 2002 726 733
25. P. Tugwell, T. Pincus, and D. Yocum Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 333 1995 137 141
26. A.J. Lehman, J.M. Esdaile, and A.V. Klinkhoff A 48-week, randomized, double-blind, double-observer, placebo-controlled, multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. Arthritis Rheum 52 2005 1360 1370
27. M.C. Genovese, J.D. McKay, and E.L. Nasonov Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study Arthritis Rheum 58 2008 2968 2980
28. M. Schiff, M. Keiserman, and C. Codding Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomized, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate Ann Rheum Dis 67 2008 1096 1103
29. K.G. Saag, G.G. Teng, and N.M. Patkar American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis Arthritis Rheum 59 2008 762 784
30. B. Combe, R. Landewe, and C. Lukas EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Published Online First: 5 January 2006 Ann Rheum Dis 66 2007 34 45 10.1136/ard.2005.044354